Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: a Randomized Trial

Launched by ROXANNE GAL · Jan 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how early access to palliative care can improve the quality of life and satisfaction with care for patients with bone metastases, which is a type of cancer that has spread to the bones. Patients who are referred for palliative radiotherapy (a treatment to relieve symptoms) will either receive a consultation with a specialized palliative care team within two weeks or continue with standard care without this consultation. The goal is to see if those who meet with the palliative care team feel more satisfied with their care and experience better quality of life.

To be eligible for this study, participants need to have bone metastases and be referred for palliative radiotherapy at one of the participating hospitals. They should also be able to understand the study's purpose and must not have previously met with the hospital's palliative care team. Throughout the trial, participants can expect to fill out questionnaires about their care and well-being. It’s important to know that this trial is still in the planning stages and hasn’t started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. broad informed consent for PRESENT+ (i.e., consent for filling out questionnaires at regular intervals and randomization into future intervention studies), and
• • 2. having their treating physician in the TIPZO-RT study site (UMC Utrecht, Radboudumc or LUMC).
• Exclusion Criteria:
• • 1. not able to understand the objective of the study (in Dutch),
• • 2. cognitive impairment or dementia, and
• • 3. has been in contact with palliative care consultants of the hospital PCCT before.